Revenue: The sum of all revenue fields included for a company's operating activities.
Urogen Pharma (URGN) had Revenue of $72.46M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$72.46M |
$-14.35M |
|
$6.57M |
|
$65.88M |
|
$72.34M |
|
$0.11M |
|
$-8.83M |
|
$-8.72M |
|
$-8.72M |
|
$-14.35M |
|
$-14.35M |
|
$-14.35M |
|
$-14.35M |
|
$0.11M |
|
$0.16M |
|
50.38M |
|
50.38M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$235.43M |
|
$0.60M |
|
$17.16M |
|
$252.59M |
|
$61.91M |
|
$191.67M |
|
$323.07M |
|
$384.99M |
|
$-132.40M |
|
$-132.40M |
|
$-132.40M |
|
48.87M |
|
| Cash Flow Statement Financials | |
$-78.32M |
|
$-19.02M |
|
$65.70M |
|
$112.09M |
|
$80.46M |
|
$-31.63M |
|
$9.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.80 |
|
-- |
|
-- |
|
3.23 |
|
-1.46 |
|
90.93% |
|
0.15% |
|
0.15% |
|
-- |
|
-12.04% |
|
-19.81% |
|
$-78.44M |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
0.27 |
|
0.82 |
|
110.25 |
|
10.84% |
|
10.84% |
|
-5.68% |
|
-24.21% |
|
$-2.71 |
|
$-1.56 |
|
$-1.55 |
|